AI-assisted, human-published
05/23/2024 /M & A
Orna Therapeutics Acquires ReNAgade Therapeutics to Advance panCAR™ in vivo CAR RNA Medicines
Orna Therapeutics has acquired ReNAgade Therapeutics to combine strengths and capabilities in driving RNA therapeutic-focused R&D. Amit D. Munshi, former CEO of ReNAgade, will lead Orna as the CEO.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com